Supplier Marketing Spend Activity in the Pharmaceutical Industry - 2012-2013 : Survey Brief
Publisher Name » ICD Research
Published Date » 2012-06-13
No. Of Pages » 48
Synopsis
Analysis of opinions drawn from leading pharmaceutical industry executives
Provides data on the current size of the marketing and advertising budgets of supplier companies in the pharmaceutical industry
Provides insight into the marketing behaviors of the global pharmaceutical industry and market competition for supplier companies
Summary
This report is the result of an extensive survey drawn from ICD Researchs exclusive panel of leading pharmaceutical industry executives. It analyzes how spending activities of the suppliers are set to change in the pharmaceutical industry in 2012-2013. This report gives you access to the category-level spending behavior of leading supply decision makers. The report also provides access to information categorized by region, company type and size.
Scope
The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior supply decision makers and leading supplier organizations.
The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
This report covers data and analysis on supplier expenditure.
Reasons To Buy
This report provides historical marketing expenditure by supplier type and region.
This report provides analysis on the changing spending behavior of suppliers by product and category.
Analysis of opinions drawn from leading pharmaceutical industry executives
Provides data on the current size of the marketing and advertising budgets of supplier companies in the pharmaceutical industry
Provides insight into the marketing behaviors of the global pharmaceutical industry and market competition for supplier companies
Summary
This report is the result of an extensive survey drawn from ICD Researchs exclusive panel of leading pharmaceutical industry executives. It analyzes how spending activities of the suppliers are set to change in the pharmaceutical industry in 2012-2013. This report gives you access to the category-level spending behavior of leading supply decision makers. The report also provides access to information categorized by region, company type and size.
Scope
The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior supply decision makers and leading supplier organizations.
The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
This report covers data and analysis on supplier expenditure.
Reasons To Buy
This report provides historical marketing expenditure by supplier type and region.
This report provides analysis on the changing spending behavior of suppliers by product and category.
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Pharmaceutical Industry Supplier Marketing Spend Activity
2.1 Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers
2.1.1 Annual marketing budgets by region: global pharmaceutical industry suppliers
2.1.2 Annual marketing budgets by company turnover: global pharmaceutical industry suppliers
2.2 Planned Change in Marketing Expenditure Levels: Global Pharmaceutical Industry Suppliers
2.2.1 Planned change in marketing expenditure by region: global pharmaceutical industry suppliers
2.2.2 Planned change in marketing expenditure by turnover: global pharmaceutical industry suppliers
2.2.3 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2012
2.3 Future Investment by Media Channel: Global Pharmaceutical Industry Suppliers
2.3.1 Future investment by media channel by region: global pharmaceutical industry suppliers
2.3.2 Future investment by media channel by company turnover: global pharmaceutical industry suppliers
2.4 Global Pharmaceutical Industry Suppliers Future Investment in Marketing and Sales
2.4.1 Investment in marketing and sales by region: global pharmaceutical industry suppliers
2.4.2 Investment in marketing and sales by region: global pharmaceutical industry suppliers
2.4.3 Investment in marketing and sales by turnover: global pharmaceutical industry suppliers
3 Appendix
3.1 Global Pharmaceutical Industry Survey Results - Closed Questions
3.2 Methodology
3.3 Contact us
3.4 About ICD Research
3.5 Disclaimer
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 9: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Table 10: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Table 11: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010-2012
Table 12: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Table 13: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Table 14: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2012
Table 15: Net Change in Planned Marketing Expenditure, All Industries Comparison (%) 2012
Table 16: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Table 17: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 18: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 19: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 20: Survey Results - Closed Questions
Figure 2: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 3: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 4: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010-2012
Figure 5: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Figure 6: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Figure 7: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Figure 8: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Region (%), 2012
Figure 9: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Turnover (%), 2012
Figure 10: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 11: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 12: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Pharmaceutical Industry Supplier Marketing Spend Activity
2.1 Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers
2.1.1 Annual marketing budgets by region: global pharmaceutical industry suppliers
2.1.2 Annual marketing budgets by company turnover: global pharmaceutical industry suppliers
2.2 Planned Change in Marketing Expenditure Levels: Global Pharmaceutical Industry Suppliers
2.2.1 Planned change in marketing expenditure by region: global pharmaceutical industry suppliers
2.2.2 Planned change in marketing expenditure by turnover: global pharmaceutical industry suppliers
2.2.3 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2012
2.3 Future Investment by Media Channel: Global Pharmaceutical Industry Suppliers
2.3.1 Future investment by media channel by region: global pharmaceutical industry suppliers
2.3.2 Future investment by media channel by company turnover: global pharmaceutical industry suppliers
2.4 Global Pharmaceutical Industry Suppliers Future Investment in Marketing and Sales
2.4.1 Investment in marketing and sales by region: global pharmaceutical industry suppliers
2.4.2 Investment in marketing and sales by region: global pharmaceutical industry suppliers
2.4.3 Investment in marketing and sales by turnover: global pharmaceutical industry suppliers
3 Appendix
3.1 Global Pharmaceutical Industry Survey Results - Closed Questions
3.2 Methodology
3.3 Contact us
3.4 About ICD Research
3.5 Disclaimer
List of Tables
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 9: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Table 10: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Table 11: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010-2012
Table 12: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Table 13: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Table 14: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2012
Table 15: Net Change in Planned Marketing Expenditure, All Industries Comparison (%) 2012
Table 16: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Table 17: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 18: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 19: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 20: Survey Results - Closed Questions
List of Figures
Figure 1: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010-2012Figure 2: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 3: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 4: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010-2012
Figure 5: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Figure 6: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Figure 7: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Figure 8: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Region (%), 2012
Figure 9: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Turnover (%), 2012
Figure 10: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 11: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 12: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Upcoming Reports:
|
Channel-In-A-Box (Ciab) Market - Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2011 - 2018
By - Transparency Market Research
Channel-in-a-box (CiaB) is defined as collapsing the pieces of traditional master control and playout chains such as switchers, graphics, servers, audio, routing and channel branding into a single integrated software application that runs on generic IT-based hardware. Channel-in-a-box technology is the next big thing in master control automation this year but most of the major hardware merchants, even those selling it warn that (CiaB) is not yet ready for every buyer. This is mainly due to the fact that TV channels differ in sophistication, and complex installations may work best with...
|
|
Home Automation Market - Global Industry Analysis, Market Size, Market Share, Growth And Forecast, 2011 - 2018
By - Transparency Market Research
Home automation helps to control basic home functions and are automatically or remotely integrated with a computer (or computers). Home automation not only improves standard of living, but also increases energy efficiency and secures lives. Basic components required to develop a well designed home automation system include a computer (or computers) with suitable programming, the systems and devices to be controlled, Wi-Fi connectivity or interconnecting cables, a high-speed internet connection, and a emergency back-up connection for computers.
The global home...
|
|
OTN Transport And Switching Equipment Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
An OTN (Optical Transport Network) is composed of a set of optical network elements, connected by optical fiber links that provides functionality of transport, multiplexing, routing, survivability, and supervision of the optical channel carrying signals. Development in 40 and 100G technologies is driving the market of OTN transport and switching equipment to a great extent, and it is expected to reach USD 10.6 billion by the end of 2015. Increasing use of OTN for transferring information signals is contributing to the growth of the OTN transport and switching equipment market....
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- Bed Linen Markets in the World to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Eastern Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Western Europe to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Asia to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Americas to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Africa to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 10 Global Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 European Countries to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in the Top 5 Asian countries to 2017 - Market Size, Trends, and Forecasts
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
